Atlas Trials

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00094848 · COMPLETED

Trial details

NCT number
NCT00094848
Sponsor
Human Genome Sciences Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Non-Hodgkin
Start date
2004-06-01
Primary completion
2006-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.